Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Signal detection of drospirenone-containing oral contraceptives: a disproportionality analysis using the Korea Adverse Event Reporting System Database, 2008-2017

Authors
Lee, YeriChoi, AhhyungNoh, YunhaJeon, Ha-LimChoe, Seung-AhShin, Ju-Young
Issue Date
2021
Publisher
BMJ PUBLISHING GROUP
Keywords
adverse events; gynaecology; epidemiology
Citation
BMJ OPEN, v.11, no.8
Indexed
SCIE
SCOPUS
Journal Title
BMJ OPEN
Volume
11
Number
8
URI
https://scholar.korea.ac.kr/handle/2021.sw.korea/138672
DOI
10.1136/bmjopen-2020-045948
ISSN
2044-6055
Abstract
Objectives To detect the signals for drospirenone-containing oral contraceptives (DCOCs) and describe the reporting pattern of adverse events (AEs) caused by DCOCs compared with levonorgestrel/desogestrel/gestodene-containing (second/third generation) oral contraceptives. Design A descriptive analysis of claims data. Setting The Korea Institute of Drug Safety & Risk Management-Korea Adverse Event Reporting System Database from 1 February 2008 to 31 December 2017. Outcome measures Signals for DCOCs were identified using three data mining indices. The characteristics, death cases, and the annual pattern of AE reports were compared between DCOCs and second/third generation oral contraceptives. Results Of the 242 DCOC-related AEs, 54 signals were detected and 10 were identified as new signals that were not included in Korea, US and UK label. The newly detected signals include deep vein thrombophlebitis and frequent urination. Serious AEs were more likely to be reported with DCOCs (7.85%) than with second/third generation oral contraceptives (2.92%). Five deaths after use of DCOCs were reported with vascular AEs, such as pulmonary embolism and thrombosis, whereas one death after use of second/third generation oral contraceptives was reported with the cardiac arrest. Conclusions We identified 10 new signals related to DCOCs that were not included in the current label. Additionally, we found higher reports of the deaths and vascular AEs associated with DCOCs than with second/third generation oral contraceptives, which warrants careful monitoring to ensure the safe use of DCOCs.
Files in This Item
There are no files associated with this item.
Appears in
Collections
Graduate School > Department of Life Sciences > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Altmetrics

Total Views & Downloads

BROWSE